Sort   by:  
 Page size 
UnknownFilgotinib Improved Health-Related Quality of Life and Led to Comprehensive Disease Control in Individuals with Ulcerative Colitis: Data from the SELECTION Trial.
Not available
S-EPMC10274306 | biostudies-literature
UnknownDaclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial.
Not available
S-EPMC1860086 | biostudies-literature
UnknownAssociation Between Proposed Definitions of Clinical Remission/Response and Well-Being in Patients With Crohn's Disease.
Not available
S-EPMC8919823 | biostudies-literature
UnknownHistopathology Scoring Systems of Stenosis Associated With Small Bowel Crohn's Disease: A Systematic Review.
Not available
S-EPMC7649049 | biostudies-literature
UnknownUse of external control arms in immune-mediated inflammatory diseases: a systematic review.
Not available
S-EPMC10729249 | biostudies-literature
UnknownEfficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial.
Not available
S-EPMC9911269 | biostudies-literature
UnknownInternational consensus to standardise histopathological scoring for small bowel strictures in Crohn's disease.
Not available
S-EPMC8903083 | biostudies-literature
UnknownAn international consensus on the design of clinical trials for advanced combination treatment (ACT) in inflammatory bowel disease.
Not available
S-EPMC12593430 | biostudies-literature
UnknownSecukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial.
Not available
S-EPMC4902107 | biostudies-literature
UnknownEvaluating treatment to a target of transmural healing in patients with moderately to severely active Crohn's disease: rationale, design and protocol for the randomised controlled VECTORS trial.
Not available
S-EPMC12927283 | biostudies-literature
Sort   by:  
 Page size